COMPANY

Notal Vision

We can provide an “on-demand” treatment regimen that is personalized to each patient’s disease activity, not the doctor’s schedule. Our remote monitoring services enable near-term and viable personalized medicine solutions, as well as the ability to partner with companies offering home-based monitoring devices using our proprietary optical coherence tomography (OCT) analyzer. From company website Source · Oct 13, 2026

Keywords: diagnostics precision medicine ophthalmology Diabetic Retinopathy Age-Related Macular Degeneration Neovascular Age-related Macular Degeneration Choroidal Neovascularization AMD Retinal Neovascularization Diabetic Macular Edema Intermediate Age Related Macular Degeneration (Disorder) AMD - Age-Related Macular Degeneration DR Population- With or Without Diabetic Macular Edema Foresee Home ForeseeHome Notal Vision Home OCT Notal OCT NOTAL OCT V2.5 PHP - Preferential Hyperacuity Perimeter (Foresee)

Profile checked Oct 10, 2026

34Trials (company is sponsor)

Timeline

Dec 15, 2022 Trial start —: ForeseeHome NRich Registry source ↗
Nov 7, 2022 Trial start —: Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT source ↗
Sep 9, 2022 Trial start —: Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD source ↗
Jun 29, 2022 Trial start —: Single In-Clinic Encounter With the Notal Vision Home OCT by DME Patients source ↗
Nov 10, 2021 Trial start —: The Evaluation of the Agreement Between the NVHO in the Automatic Fluid Quantification and Cirrus OCT source ↗
Sep 13, 2021 Trial start —: Home OCT Repeatability and Reproducibility of Automatic Fluid Quantification Study source ↗
Jun 17, 2021 Trial start —: Home OCT Fluid Visualization Agreement Study source ↗
Dec 8, 2020 Trial start —: Daily Testing at Home by NV-AMD Subjects With Notal Home OCT. source ↗
Nov 16, 2020 Trial start —: Single In-Clinic Encounter With the Notal Vision Home OCT source ↗
Jun 9, 2020 Trial start —: Home Retinal Imaging Using NOTAL-OCT V3.0 source ↗
Dec 2, 2019 Trial start Not phased (device or behavioral study): Retinal Imaging Using NOTAL-OCT V3.0 source ↗
Oct 20, 2018 Trial start —: NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients source ↗
Jul 22, 2018 Trial start —: Retinal Imaging Using NOTAL-OCT V2.5 source ↗
Sep 30, 2017 Trial start Not phased (device or behavioral study): Usability and Ergonomic Evaluation of Self-Positioning System for Retinal Imaging source ↗
Mar 14, 2017 Trial start —: Macular Thickness Measurements Using Retinal-thickness OCT source ↗
Jan 17, 2017 Trial start —: Retinal Imaging Using NOTAL-OCT source ↗
2011-04 Trial start —: Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration source ↗
2010-05 Trial start Not phased (device or behavioral study): HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device source ↗
2009-12 Trial start —: Foresee Home for Monitoring Age Related Macular Degeneration (AMD) source ↗
2009-10 Trial start —: Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment source ↗
2009-09 Trial start —: Age-Related Macular Degeneration (AMD) - Usability Study source ↗
2009-08 Trial start —: Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV) source ↗
2009-06 Trial start —: Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects source ↗
2009-02 Trial start —: Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients source ↗
2008-11 Trial start —: Usability of the PreView PHP for Home Use in Intermediate AMD Patients source ↗

Showing 25 of 33 dated events.

Upcoming milestones

Dec 15, 2027 (ESTIMATED) · · ForeseeHome NRich Registry · NCT05690880

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 34

Record	Title	Phase	Status	Start	Primary completion
NCT05417152	Single In-Clinic Encounter With the Notal Vision Home OCT by DME Patients	Not listed	Completed	Jun 29, 2022	Nov 30, 2022 (actual)
NCT04078672	Retinal Imaging Using NOTAL-OCT V3.0	Not phased (device or behavioral study)	Completed	Dec 2, 2019	Jan 30, 2023 (actual)
NCT04241198	Home Retinal Imaging Using NOTAL-OCT V3.0	Not listed	Completed	Jun 9, 2020	Jul 30, 2022 (actual)
NCT05650047	Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD	Not listed	Unknown status (ClinicalTrials.gov)	Sep 9, 2022	Jul 26, 2023 (estimated)
NCT05745116	Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT	Not listed	Unknown status (ClinicalTrials.gov)	Nov 7, 2022	Jul 31, 2023 (estimated)
NCT05690880	ForeseeHome NRich Registry	Not listed	Active, not recruiting	Dec 15, 2022	Dec 15, 2027 (estimated)
NCT05202587	The Evaluation of the Agreement Between the NVHO in the Automatic Fluid Quantification and Cirrus OCT	Not listed	Completed	Nov 10, 2021	Jan 12, 2023 (actual)
NCT05281042	Home OCT Repeatability and Reproducibility of Automatic Fluid Quantification Study	Not listed	Completed	Sep 13, 2021	Nov 30, 2021 (actual)
NCT04907409	Home OCT Fluid Visualization Agreement Study	Not listed	Unknown status (ClinicalTrials.gov)	Jun 17, 2021	Jul 30, 2022 (estimated)
NCT04642183	Single In-Clinic Encounter With the Notal Vision Home OCT	Not listed	Completed	Nov 16, 2020	Aug 24, 2021 (actual)
NCT04650672	Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.	Not listed	Completed	Dec 8, 2020	Aug 4, 2021 (actual)
NCT03374020	Retinal Imaging Using NOTAL-OCT	Not listed	Completed	Jan 17, 2017	May 14, 2018 (actual)
NCT03600519	Retinal Imaging Using NOTAL-OCT V2.5	Not listed	Completed	Jul 22, 2018	Feb 18, 2019 (actual)
NCT03969303	NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients	Not listed	Completed	Oct 20, 2018	Jul 11, 2019 (actual)
NCT01103505	HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device	Not phased (device or behavioral study)	Completed	2010-05	2013-10 (actual)
NCT03030729	Macular Thickness Measurements Using Retinal-thickness OCT	Not listed	Completed	Mar 14, 2017	Jan 14, 2018 (actual)
NCT03270865	Usability and Ergonomic Evaluation of Self-Positioning System for Retinal Imaging	Not phased (device or behavioral study)	Completed	Sep 30, 2017	Feb 1, 2018 (actual)
NCT01336907	Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)	Not listed	Withdrawn	Not listed	Not listed
NCT00604071	Sensitivity of the Home Macular Perimeter (HMP)	Not listed	Completed	2007-11	2008-09 (actual)
NCT00592826	HMP (Home Macular Perimeter) -Usability Trial	Not listed	Completed	2007-11	2008-01 (actual)
NCT00603850	Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP)	Not listed	Completed	2008-01	2008-04 (actual)
NCT00884637	Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects	Not listed	Completed	2009-06	2013-12 (actual)
NCT01334294	Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration	Not listed	Completed	2011-04	2013-12 (actual)
NCT01073592	Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)	Not listed	Completed	2009-08	2013-01 (actual)
NCT00748384	Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients	Not listed	Completed	2009-02	2013-03 (actual)
NCT00596388	Usage of the Home Macular Perimeter (HMP)	Not listed	Completed	2008-03	2013-01 (actual)
NCT01010997	Foresee Home for Monitoring Age Related Macular Degeneration (AMD)	Not listed	Completed	2009-12	2012-01 (actual)
NCT01083147	Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment	Not listed	Completed	2009-10	2010-03 (actual)
NCT00963339	Age-Related Macular Degeneration (AMD) - Usability Study	Not listed	Completed	2009-09	2009-12 (actual)
NCT00776451	Usability of the PreView PHP for Home Use in Intermediate AMD Patients	Not listed	Completed	2008-11	2009-02 (actual)
NCT00692887	Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV)	Not listed	Completed	2008-06	2008-12 (actual)
NCT00595998	Sensitivity and Specificity of the Home Macular Perimeter (HMP)	Not listed	Completed	2008-01	2008-09 (actual)
NCT00359008	PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)	Not listed	Completed	2006-07	Not listed
NCT00358345	PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization	Not listed	Completed	2003-10	Not listed